Page last updated: 2024-08-18

pyrroles and Basal Ganglia Diseases

pyrroles has been researched along with Basal Ganglia Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Audinot, V; Brocco, M; Dekeyne, A; Gobert, A; Lejeune, F; Millan, MJ; Newman-Tancredi, A; Nicolas, JP; Peglion, JL; Rivet, JM; Schreiber, R; Spedding, M	1

Other Studies

1 other study(ies) available for pyrroles and Basal Ganglia Diseases

Article	Year
S 18126 ([2-[4-(2,3-dihydrobenzo[1,4]dioxin-6-yl)piperazin-1-yl methyl]indan-2-yl]), a potent, selective and competitive antagonist at dopamine D4 receptors: an in vitro and in vivo comparison with L 745,870 (3-(4-[4-chlorophenyl]piperazin-1-yl)methyl-1H- The Journal of pharmacology and experimental therapeutics, 1998, Volume: 287, Issue:1 Topics: Animals; Basal Ganglia Diseases; Body Temperature; Brain; Dioxins; Dopamine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Male; Mice; Piperazines; Pyridines; Pyrroles; Raclopride; Rats; Rats, Wistar; Receptors, Dopamine D4; Receptors, sigma; Salicylamides; Serotonin	1998

Article

Year

S 18126 ([2-[4-(2,3-dihydrobenzo[1,4]dioxin-6-yl)piperazin-1-yl methyl]indan-2-yl]), a potent, selective and competitive antagonist at dopamine D4 receptors: an in vitro and in vivo comparison with L 745,870 (3-(4-[4-chlorophenyl]piperazin-1-yl)methyl-1H-

The Journal of pharmacology and experimental therapeutics, 1998, Volume: 287, Issue:1

Topics: Animals; Basal Ganglia Diseases; Body Temperature; Brain; Dioxins; Dopamine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Male; Mice; Piperazines; Pyridines; Pyrroles; Raclopride; Rats; Rats, Wistar; Receptors, Dopamine D4; Receptors, sigma; Salicylamides; Serotonin

1998